In vitro-in vivo characterization of gentamicin bone implants

Journal of Controlled Release

Volumn 83, Issue 3, 2002, Pages 353-364

  Baro, M ^a   Sanchez E ^b   Delgado, A ^b   Perera, A ^c   Evora C ^b  

^a Servicio De Traumatología   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

Author keywords

Bone infection; Calcium phosphates; Gentamicin implants; Osteomyelitis; Poly(lactic acid)

Indexed keywords

CALCIUM PHOSPHATE; GENTAMICIN; POLYLACTIDE; RESOMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE INFECTION; BONE TISSUE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DELAYED DRUG RELEASE; DRUG BONE LEVEL; DRUG DEGRADATION; DRUG DIFFUSION; DRUG FORMULATION; DRUG IMPLANT; DRUG SYNTHESIS; EXPERIMENTAL DESIGN; FEMUR; FILM COATING; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RABBIT; WEIGHT;

ANIMALS; BONE AND BONES; CHEMISTRY, PHARMACEUTICAL; DRUG CARRIERS; DRUG IMPLANTS; GENTAMICINS; MALE; RABBITS;

EID: 0037202182     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00179-7     Document Type: Article

References (29)

1. Ciampolini J., Harding K.G. Pathophysiology of chronic bacterial osteomyelitis. Why do antibiotics fail so often? Postgrad. Med. J. 76:(898):2000;479-483.
2. Shinto Y., Uchida A., Korkusuz F., Araki N., Ono K. Calcium hydroxyapatite ceramic used as a delivery system for antibiotics. J. Bone Joint Surg. Br. 74:1992;600-604.
3. Yu D., Wong J., Matsuda Y., Fox J.L., Higuchi W.I., Otsuka M. Self-setting hydroxyapatite cement: A novel skeletal drug-delivery system for antibiotics. J. Pharm. Sci. 81:(6):1992;521-529.
4. Lambotte J.C., Thomazeau H., Cathelineau G., Lancien G., Minet J., Langlais F. Tricalcium phosphate an antibiotic carrier: a study focused on experimental osteomyelitis in rabbits. Chirurgie. 123:(6):1998;572-579.
5. Yamashita Y., Uchida A., Yamakawa T., Shinto Y., Araki N., Kato K. Treatment of chronic osteomyelitis using calcium hydroxyapatite ceramic implants impregnated with antibiotic. Int. Orthop. 22:(4):1998;247-251.
6. Schmidt C., Wenz R., Nies B., Moll F. Antibiotic in vivo/in vitro release, histocompatibility and biodegradation of gentamicin implants based on lactic acid polymers and copolymers. J. Control. Release. 37:1995;83-94.
7. Kanellakopoulou K., Galanakis N., Giamarellos-Bourboulis E.J., Rifiotis C., Papakostas K., Andreopoulos A., Dounis E., Karagianakos P., Giamarellou H. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing perfloxacin. J. Antimicrob. Chemother. 46:(2):2000;311-314.
8. Wei G., Kotoura Y., Oka M., Yamamuro T., Wada R., Hyon S., Ikada Y. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. J. Bone Joint Surg. Br. 73:1991;246-252.
9. Overbeck J.P., Winckler S.T., Meffert R., Tormala P., Spiegel H.V., Brug E. Penetration of ciprofloxacin into bone: a new bioabsorbable implant. J. Invest. Surg. 8:(3):1995;155-162.
10. Garvin K.L., Miyano J.A., Robinson D., Giger D., Novak J., Radio S. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model. J. Bone Joint Surg. Am. 76:(10):1994;1500-1506.
11. Calhoun J.H., Mader J.T. Treatment of osteomyelitis with a biodegradable antibiotic implant. Clin. Orthop. 341:1997;206-214.
12. Sasaki S., Ishii Y. Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis. J. Orthop. Sci. 4:(5):1999;361-369.
13. Soriano I., Évora C. Formulation of calcium phosphates/poly(DL-lactide) blends containing gentamicin for bone implantation. J. Control. Release. 68:2000;121-134.
14. Sánchez E., Baro M., Soriano I., Perera A., Évora C. In vivo-in vitro study of biodegradable and osteointegrable gentamicin bone implants. Eur. J. Pharm. Biopharm. 52:2001;151-158.
15. Laurencin C.T., Gerhart T., Witscheger P., Domb A., Rosenberg A.E., Hanff P., Edsberg L., Hayes W., Langer R. Bioerodible polyanhydrides for antibiotic drug delivery: in vivo osteomyelitis. J. Orthop. Res. 11:(2):1993;256-262.
16. Leyh R.G., Bartels C., Sievers H.H. Adjuvant treatment of deep sternal wound infection with collagenous gentamycin. Ann. Thorac. Surg. 68:(5):1999;1648-1651.
17. Aimin C., Chunlin H., Juliang B., Tinyin Z., Zhichao D. Antibiotic loaded chitosan bar. An in vitro, in vivo study of a possible treatment for osteomyelitis. Clin. Orthop. 366:1999;239-247.
18. Yagmurlu M.F., Korkusuz F., Gürsel I., Korkusuz P., Ors U., Hasirci V. Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system: in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. J. Biomed. Mater. Res. 46:(4):1999;494-503.
19. Gürsel I., Korkusuz F., Türesin F., Alaeddinoglu N.G., Hasirci V. In vivo application of biodegradable controlled antibiotic release systems for the treatment of implant-related osteomyelitis. Biomaterials. 22:(1):2001;73-80.
20. Zhang X., Wyss U.P., Pichora D., Goosen M.F.A. A mechanistic study of antibiotic release from biodegradable poly(D,L-lactide) cylinders. J. Control. Release. 31:1994;129-144.
21. Stephens D., Li L., Robinson D., Chen S., Chang H.-C., Liu R.M., Tian Y., Ginsburg E.J., Gao X., Stultz T. Investigation of the in vitro release of gentamicin from a polyanhydride matrix. J. Control. Release. 63:2000;305-317.
22. Hedayat A., Wallis W.D. Hadamard matrices and their applications. Ann. Stat. 6:1978;1184-1188.
23. Zhang X., Wyss U.P., Pichora D., Goosen M.F.A. Biodegradable controlled antibiotic release devices for osteomyelitis: optimization of release properties. J. Pharm. Pharmacol. 46:1994;718-724.
24. Micrometrics . Instruction Manual: pore size 9305. 1984;Micromeritics, Norcross.
25. Gucluyildiz H., Banker G.S., Peck G.E. Determination of porosity and pore-size distribution of aspirin tablets relevant to drug stability. J. Pharm. Sci. 66:(3):1977;407-414.
26. Wikberg M., Alderborn G. Compression characteristics of granulated materials. Part 6. Pore size distributions, assessed by mercury penetration, of compacts of two lactose granulations with different fragmentation propensities. Int. J. Pharm. 84:1992;191-195.
27. Tracy M.A., Ward K.L., Firouzabadian L., Wang I., Dong N., Qian R., Zhang Y. Factors affecting the degradation rate of poly(lactide-co-glycolide) microspheres in vivo and in vitro. Biomaterials. 20:1999;1057-1062.
28. Liu L., Li S., Garreau H., Vert M. Selective enzymatic degradations of poly(L-lactide) and poly(epsilon-caprolactone) blend films. Biomacromolecules. 3:2000;350-359.
29. Lu L., Peter S.J., Lyman M.D., Lai H., Leite S.M., Tamada J.A., Uyama S., Vacanti J.P., Langer R., Mikos A.G. In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials. 21:2000;1837-1845.